TW200501951A - Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis - Google Patents
Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritisInfo
- Publication number
- TW200501951A TW200501951A TW093117155A TW93117155A TW200501951A TW 200501951 A TW200501951 A TW 200501951A TW 093117155 A TW093117155 A TW 093117155A TW 93117155 A TW93117155 A TW 93117155A TW 200501951 A TW200501951 A TW 200501951A
- Authority
- TW
- Taiwan
- Prior art keywords
- fibromyalgia
- treatment
- rheumatoid arthritis
- neuropathic pain
- gaboxadol
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
The present invention relates to the use of Gaboxadol for the preparation of medicaments useful for the treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300955 | 2003-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200501951A true TW200501951A (en) | 2005-01-16 |
Family
ID=42778303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093117155A TW200501951A (en) | 2003-06-25 | 2004-06-15 | Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR044884A1 (en) |
TW (1) | TW200501951A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11123332B2 (en) | 2018-11-21 | 2021-09-21 | Certego Therapeutics Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
US11597726B2 (en) | 2020-05-20 | 2023-03-07 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
-
2004
- 2004-06-15 TW TW093117155A patent/TW200501951A/en unknown
- 2004-06-23 AR ARP040102199A patent/AR044884A1/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11123332B2 (en) | 2018-11-21 | 2021-09-21 | Certego Therapeutics Inc. | Gaboxadol for reducing risk of suicide and rapid relief of depression |
US11597726B2 (en) | 2020-05-20 | 2023-03-07 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
Also Published As
Publication number | Publication date |
---|---|
AR044884A1 (en) | 2005-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL175770A0 (en) | Novel use of peptide compounds for treating central neuropathic pain | |
TW200508214A (en) | Novel compounds | |
TW200508201A (en) | Novel process for the preparation of roflumilast | |
SI1480961T1 (en) | Glutaminyl based dpiv inhibitors | |
NO20070440L (en) | Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis | |
TW200505875A (en) | Novel compounds | |
UA86599C2 (en) | Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides | |
HK1094421A1 (en) | (S)-2-n-propylamino-5-hydroxytetralin as a d3-agonist | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
MY128924A (en) | Novel compounds | |
MX2009011346A (en) | Tapentadol for treating pain from arthritis. | |
EP1545510A4 (en) | Substituted phenylindoles for the treatment of hiv | |
TW200621260A (en) | Selected fused heterocyclics and uses thereof | |
HRP20050611A2 (en) | Combination medicament | |
TW200504402A (en) | Antimicrobial lenses, processes to prepare them and methods of their use | |
MXPA06004308A (en) | Isopentyl carboxanilides for combating undesired micro-organisms. | |
MXPA04000446A (en) | Substituted 4-aminocyclohexanols. | |
DK1485057T3 (en) | Derivatives of azaspiro compounds for the treatment of pain | |
MXPA06002315A (en) | Erg channel openers for the treatment of cardiac arrhythmias. | |
TW200501951A (en) | Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis | |
MXPA04004090A (en) | Substituted 1h-quinolin-2-one compounds. | |
UA87117C2 (en) | Use of peptide compounds for treatment of central neuropatic pain | |
GB0330049D0 (en) | The treatment of neuropathic pain conditions | |
AU2003266960A1 (en) | Composition for the treatment of pain, especially for the treatment of articular pain | |
PT1590046T (en) | Composition for the treatment of hiv or aids |